Results of the Cox Model
| . | HR4-150 . | Estimated 95% CI . | P4-151 . |
|---|---|---|---|
| TEL/AML1 | |||
| Negative | 1 | ||
| Positive | 0.29 | 0.09-0.97 | 0.044 |
| Sex | |||
| Male | 1 | ||
| Female | 0.72 | 0.34-1.53 | 0.396 |
| Age (yr) | |||
| <6 | 1 | ||
| ≥6 | 2.49 | 1.18-5.24 | 0.016 |
| WBC | |||
| <20,000 | 1 | ||
| 20-100,000 | 0.65 | 0.22-1.95 | 0.443 |
| ≥100,000 | 3.94 | 1.61-9.67 | 0.003 |
| Immunophenotype | |||
| Common | 1 | ||
| Pre-B or pre-pre-B | 2.84 | 1.34-6.00 | 0.006 |
| Protocol | |||
| BFM | 1 | ||
| AIEOP | 1.35 | 0.58-3.13 | 0.487 |
| . | HR4-150 . | Estimated 95% CI . | P4-151 . |
|---|---|---|---|
| TEL/AML1 | |||
| Negative | 1 | ||
| Positive | 0.29 | 0.09-0.97 | 0.044 |
| Sex | |||
| Male | 1 | ||
| Female | 0.72 | 0.34-1.53 | 0.396 |
| Age (yr) | |||
| <6 | 1 | ||
| ≥6 | 2.49 | 1.18-5.24 | 0.016 |
| WBC | |||
| <20,000 | 1 | ||
| 20-100,000 | 0.65 | 0.22-1.95 | 0.443 |
| ≥100,000 | 3.94 | 1.61-9.67 | 0.003 |
| Immunophenotype | |||
| Common | 1 | ||
| Pre-B or pre-pre-B | 2.84 | 1.34-6.00 | 0.006 |
| Protocol | |||
| BFM | 1 | ||
| AIEOP | 1.35 | 0.58-3.13 | 0.487 |
Abbreviations: HR, hazard ratio; CI, confidence interval.
In the HR column, 1 identifies the reference category, an HR < 1 (>1) indicates that the risk of failure (relapse or death) in the corresponding group is less (more) than the risk of failure in the reference group.
P according to the Wald test.